undamentalytics Newsletter

Ibio, Inc. balance sheet

At the end of fiscal 2026, Ibio, Inc. had total assets of $99.1m, total liabilities of $13.4m and shareholders' equity of $85.7m. It held $56.4m in cash against $0 of debt: net cash of $56.4m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Ibio, Inc.: balance sheet, annual
Fiscal year2011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026
Cash and equivalents36449161644557723414956
Receivables00100000000100——
Inventory——————————0400——
Total current assets477410249165621054526161092
Total assets710961252364331941479941292399
Accounts payable3320111112242024
Deferred revenue (current)———————012000011
Total current liabilities7440122235730224612
Long-term debt————————000——1——
Total debt00000000011—13110
Total liabilities———0128272728383836267813
Shareholders' equity065611109162571096315211586
Non-controlling interests and other (assets − liabilities − equity)—————14——————————
Net debt (negative = net cash)−3−6−4−4−9−16−16−4−4−55−77−239−13−7−56
Shares outstanding————————————6m—97m111m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IBIO vs LSTAAIM vs IBIOCLDX vs IBIOCLNN vs IBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Ibio, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ibio, Inc.